Polyrizon partners with Clearmind to develop intranasal MEAI formulation

Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 0.97 -0.01 (1.02%)
Previous Close $0.98    52 Week High
Open $1.00    52 Week Low
Day High $1.06    P/E N/A 
Day Low $0.95    EPS
Volume 288,315       

(NASDAQ: PLRZ) Delayed: 11.03 -0.2 (1.78%)
Previous Close $11.23    52 Week High
Open $11.19    52 Week Low
Day High $11.36    P/E N/A 
Day Low $10.50    EPS
Volume 76,585